| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |